Literature DB >> 18095744

Methods for causality assessment of adverse drug reactions: a systematic review.

Taofikat B Agbabiaka1, Jelena Savović, Edzard Ernst.   

Abstract

Numerous methods for causality assessment of adverse drug reactions (ADRs) have been published. The aim of this review is to provide an overview of these methods and discuss their strengths and weaknesses. We conducted electronic searches in MEDLINE (via PubMed), EMBASE and the Cochrane databases to find all assessment methods. Thirty-four different methods were found, falling into three broad categories: expert judgement/global introspection, algorithms and probabilistic methods (Bayesian approaches). Expert judgements are individual assessments based on previous knowledge and experience in the field using no standardized tool to arrive at conclusions regarding causality. Algorithms are sets of specific questions with associated scores for calculating the likelihood of a cause-effect relationship. Bayesian approaches use specific findings in a case to transform the prior estimate of probability into a posterior estimate of probability of drug causation. The prior probability is calculated from epidemiological information and the posterior probability combines this background information with the evidence in the individual case to come up with an estimate of causation. As a result of problems of reproducibility and validity, no single method is universally accepted. Different causality categories are adopted in each method, and the categories are assessed using different criteria. Because assessment methods are also not entirely devoid of individual judgements, inter-rater reliability can be low. In conclusion, there is still no method universally accepted for causality assessment of ADRs.

Mesh:

Year:  2008        PMID: 18095744     DOI: 10.2165/00002018-200831010-00003

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  59 in total

1.  The Food and Drug Administration algorithm. Special workshop--regulatory.

Authors:  W M Turner
Journal:  Drug Inf J       Date:  1984

2.  The Bayesian differential diagnosis of neutropenia associated with antiarrhythmic agents.

Authors:  C A Naranjo; K L Lanctôt; D A Lane
Journal:  J Clin Pharmacol       Date:  1990-12       Impact factor: 3.126

Review 3.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Proposal for a new tool to evaluate drug interaction cases.

Authors:  John R Horn; Philip D Hansten; Lingtak-Neander Chan
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

5.  A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barré syndrome and zimeldine.

Authors:  C A Naranjo; D Lane; M Ho-Asjoe; K L Lanctôt
Journal:  J Clin Pharmacol       Date:  1990-02       Impact factor: 3.126

6.  Computer-assisted evaluation of adverse events using a Bayesian approach.

Authors:  K L Lanctôt; C A Naranjo
Journal:  J Clin Pharmacol       Date:  1994-02       Impact factor: 3.126

7.  Reasons for disagreement in the standardized assessment of suspected adverse drug reactions.

Authors:  T A Hutchinson; K M Flegel; H HoPingKong; W S Bloom; M S Kramer; E G Trummer
Journal:  Clin Pharmacol Ther       Date:  1983-10       Impact factor: 6.875

8.  Standardized assessment of drug-adverse reaction associations--rationale and experience.

Authors:  J Venulet; A Ciucci; G C Berneker
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980-09

9.  An algorithm for the operational assessment of adverse drug reactions. III. Results of tests among clinicians.

Authors:  J M Leventhal; T A Hutchinson; M S Kramer; A R Feinstein
Journal:  JAMA       Date:  1979-11-02       Impact factor: 56.272

10.  Enhanced differential diagnosis of anticonvulsant hypersensitivity reactions by an integrated Bayesian and biochemical approach.

Authors:  C A Naranjo; M C Kwok; K L Lanctôt; H P Zhao; S P Spielberg; N H Shear
Journal:  Clin Pharmacol Ther       Date:  1994-11       Impact factor: 6.875

View more
  94 in total

1.  Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.

Authors:  Hélène Théophile; Yannick Arimone; Ghada Miremont-Salamé; Nicholas Moore; Annie Fourrier-Réglat; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 2.  Adverse drug reactions in older people: detection and prevention.

Authors:  Mirko Petrovic; Tischa van der Cammen; Graziano Onder
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 3.  The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015.

Authors:  Roni P Dodiuk-Gad; Cristina Olteanu; Wen-Hung Chung; Neil H Shear
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

4.  Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.

Authors:  Hélène Théophile; Manon André; Ghada Miremont-Salamé; Yannick Arimone; Bernard Bégaud
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

5.  Serious adverse drug events related to non-investigational drugs in academic clinical trials: another source of safety data for risk assessment?

Authors:  Pascale Olivier; Anne Gimbert; Anne-Laurène Colin; Francesco Salvo; Madlyne Becker; Valérie Marty; Jean-Louis Montastruc; Nadine Petitpain
Journal:  Br J Clin Pharmacol       Date:  2016-07-13       Impact factor: 4.335

6.  Published cases of adverse drug reactions: has the quality of reporting improved over time?

Authors:  Sandra L Kane-Gill; Pamela L Smithburger; Evan A Williams; Maria A Felton; Nan Wang; Amy L Seybert
Journal:  Ther Adv Drug Saf       Date:  2015-04

7.  Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort study.

Authors:  Neža Muhič; Ales Mrhar; Miran Brvar
Journal:  Eur J Clin Pharmacol       Date:  2017-03-15       Impact factor: 2.953

8.  Comparison of different methods for causality assessment of adverse drug reactions.

Authors:  Sapan Kumar Behera; Saibal Das; Alphienes Stanley Xavier; Srinivas Velupula; Selvarajan Sandhiya
Journal:  Int J Clin Pharm       Date:  2018-07-26

9.  Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.

Authors:  Erik Scalfaro; Henk Johan Streefkerk; Michael Merz; Christoph Meier; David Lewis
Journal:  Drug Saf       Date:  2017-08       Impact factor: 5.606

Review 10.  Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.

Authors:  Rolf Teschke; Albrecht Wolff; Christian Frenzel; Alexander Schwarzenboeck; Johannes Schulze; Axel Eickhoff
Journal:  World J Hepatol       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.